New pathophysiological concepts on aspirin hypersensitivity (Widal syndrome); diagnostic and therapeutic consequences;Nouvelles données pathophysiologiques sur l'hypersensibilité à l'aspirine (syndrome de Widal); conséquences diagnostiques et thérapeutiques

Bulletin de l'Academie Nationale de Medecine

Volumn 189, Issue 6, 2005, Pages 1201-1220

  De Weck, Alain ^a   Sanz, Maria Luisa ^b   Gamboa, Pedro ^c   Nordmann, Roger ^d   Rochemaure, Jacques ^d   Menkès, Charles Joël ^d   Molina, Claude ^d   Michel, François Bernard ^d  

^a Académie Nationale de Médecine   (Switzerland)

^b UNIVERSITY OF NAVARRA   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

^d NONE

Author keywords

Antiinflammatory agents, non steroidal; Aspirin; Asthma; Diagnosis; Flow cytometry; Hypersensibility

Indexed keywords

EID: 30344486669     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33483-1     Document Type: Article

References (73)

1. WIDAL M.F., ABRANI P., LERMOYEZ J. - Anaphylaxie et idiosyncrasie. Presse Méd., 1922, 30, 189-192
2. - Nachdruck in: Allergy Proc., 1993, 14, 373-376.
3. SZCZEKLIK A., STEVENSON D. - Aspirin-induced asthma: Advances in pathogenesis, diagnosis and management. J. Allergy Clin. Immunol., 2003, 111, 913-921.
4. SZCZEKLIK A., STEVENSON D.D. - Aspirin-induced asthma: Advances in pathogenesis and management. J. Allergy. Clin. Immunol., 1999, 104, 5-13.
5. KASPER L., SLADEK K., DUPLAGA M., BOCHENEK G., LIEBHARD J., GLADYSZ U., MALOPEPSZY J., SZCZWKLIK A. - Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy, 2003, 58, 1084-1066.
6. FAICH G.A. - Adverse drug reaction monitoring. N. Engl. J. Med., 1986, 314, 1589-1592.
7. SAINTE-LAUDY J. - Nine cases of suspected IgE-mediated anaphylaxis induced by aspirin. ACI International, 2002, 14, 220-222.
8. BLANCA M., PEREZ E., GARCIA J.J. et al. - Angioedema and IgE antibodies to aspirin: a case report. Ann. Allerg., 1989, 62, 295-298.
9. SZCZEKLIK A., GRYGLEWSKI R.J., CZERMAVSKA-MYSIK G. - Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br. Med J., 1975, 1, 67-69.
10. SZCZEKLIK A. - The cyclooxygenase theory of aspirin-induced asthma. Eur. Respir. J., 1990, 3, 588-593.
11. FISCHER A.R., ROSENBERG M.A., LILLY C.M., CALLERY J.C., RUBIN P., COHN J., WHITE M.V., IGARASHI Y., KALINER M.A., DRAZEN J.M., ISRAEL E. - Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J. Allergy. Clin. Immunol., 1994, 94, 1046-1056.
12. O'SULLIVAN S., DAHLEN B., DAHLEN S.-E., KUMLIN M. - Increased urinary excretion of the prostaglandin D2 metabolite 9α, 11β-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J. Allergy. Clin. Immunol., 1996, 98, 421-432.
13. BOCHENEK G., NAGRABA K., NIZANDOWSKA E., SZCZEKLIK A. - A controlled study of 9α, 11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls following the aspirin challenge. J. Allergy. Clin. Immunol., 2003, 111, 743-749.
14. LEE T.H., SMITH C.M., ARM J.P., CHRISTIE P.E. - Mediator release in aspirin-induced reactions. J. Allergy. Clin. Immunol., 1991, 88, 827-829.
15. COWBURN A.S., SLADEK K., SOJA J., AADAMEK L., NIZANKOWSKA E., SZCZEKLIK A., LAM B.K., PENTROSE J.F., AUSTEN K.F., HOLGATE ST., SAMPSON A.P. - Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J. Clin. Invest., 1998, 101, 834-846.
16. SANAK M., SIMON H-U., SZCZEKLIK A. - Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet, 1997, 350, 1599-2000.
17. SANAK M., SZCZEKLIK A. - Genetics of aspirin induced asthma. Thorax, 2000, 55 (Suppl 2), S45-S47.
18. TORRES-GALVAN M.J., ORTEGA N., SANCHEZ-GARCIA F., BLANCO C., CARILLO T., QUIRALTE J. - LTC4-synthase A-444C polymorphism: lack of association with NSAID-induced isolated periorbital angioedema in a Spanish population Ann. Allergy. Asthma. Immunol., 2001, 87, 506-510.
19. VAN SAMBECK R., STEVENSON D.D., BALDASARO M., LAM B.K., ZHAO J.L., YOSHIDA S., YANDORA C., DOS J.M., PENROSE J.F. - 5′Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J. Allergy. Clin. Immunol., 2000, 106, 72-76.
20. KAWAGASHI Y., MITA H., TANIGUCHI M., MARUYAMA M., OSAKI R., HIGASHI N., KASHII T., KOBAYASHI M., AKYAMA K. - Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. J. Allergy Clin. Immunol., 2002, 109, 936-942.
21. DEMOLY P. - Mise au point sur l'intolérance à l'aspirine et aux AINS. Allergologie Pratique, 2003, 4, No 66.
22. CZECH W., KAPP A., KOWNATZKI E., SCHOPF E. - Die Bedeutung der in vitro-induzierten Histaminfreisetzung aus isolierten Leukozyten für die Diagnostik pseudo-allergischer Reaktionen auf Azetylsalizylsäure. Allergologie, 1990, 13, 201-204.
23. LEBEL B., MESSAAD B., KVEDARIENE V., RONGIER M., BOUSQUET J., DEMOLY P. - Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactions. Allergy, 2001, 56, 688-692.
24. DE WECK A.L., STADLER B.H., URWYLER A., WECHSNER H.U., BUHLMANN R.P. - Cellular antigen stimulation test (CAST): a new dimension in allergy diagnosis. Allergy. Clin. Immunol., News, 1993, 5, 9-14.
25. DE WECK A.L. - Zellulärer Allergen De Stimulierungs-Test (CAST). Eine Uebersicht und kritische Auswertung der klinischen Anwendung in der Allergiediagnose. Allergologie, 1997, 20, 487-502.
26. FERRER M., SANZ M.L., PRIETO I., OEHLING A. - In vitro antigen-specific sulphidoleukotriene production in patients allergic to Dermatophagoides pteronyssinus. Clin. Exp. Allergy, 1998, 28, 709-714.
27. MALY F.E., MARTI-WYSS S., BLUMER S., CUHAT-STARK I., WUHTRICH B. - Mononuclear blood cell sulfidoleukotriene generation in the presence of interleukin-3 and whole blood histamine release in koney bee and yellow jacket venom allergy. J. Invest. Allergol. Clin. Immunol., 1997, 7, 217-224.
28. SANZ M.L., GAMBOA P.M., GARCIA-AVILES C., VILA L., DIEGUEZ I., AANTEPARA I., DE WECK A.L. - Flow-cytometric cellular alllergen stimulation test in latex allergy. Int. Arch. Allergy Immunol., 2003, 130, 33-39.
29. MONERET-VAUTRIN D., SAINTE-LAUDY J., KANNY G., FREMONT S. - Human basophil activation measured by CD63 expression and LTC4 release in IgE-mediated food allergy. Ann. Allergy Asthma Immunol., 1999, 82, 33-4.
30. VILA L. SANZ M.L., SANCHEZ G., UASUF G., FERRER M., BARRIO M., DIEGUEZ I. - Study of the in vitro sulphidoleukotriene production in food allergic patients. J. Investig. Allergol. Clin. Immunol., 2001, 11, 247-254.
31. SANZ M.L., GAMBOA P.M., DE WECK A.L. - Clinical evaluation of in vitro diagnostic tests in diagnosis of immediate allergic reactions to β-lactam antibiotics. ACI International, 2002, 14, 185-193.
32. GAMBOA P.M., SANZ M.L., CABALLERO M.R., ANTEPARA I., URRUTIA I., JAUREGUI I., GONZALES G., DIEGUEZ I., DE WECK A.L. - Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy, 2003, 58, 312-317.
33. SANZ M.L., GAMBOA P., DE WECK A.L. - A new combined test with flowcytometric basophil activation (FAST) and determination of sulfidoleukotrienes (CAST) is useful for in vitro diagnosis of hypersensitivity to aspirin and other non steroidal anti-inflammatory drugs (NSAIDs). Int. Arch. Allergy Immunol., 2004 (in press).
34. GAMBOA P., SANZ M.L., CABALLERO M.R., URRUTIA I., ANTEPARRA I., DE WECK A.L. - The flowcytometric determination of basophil activation induced by aspirin and other non steroidal antgi-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin. Exp. Allergy., 2004 (in press).
35. BENVENISTE J. - The human basophil degranulation test as an in vitro method for diagnosis of allergies. Clin. Allergy, 1981, 11, 1-11.
36. KNOL E.F., MUL F.P.J., JANSEN H., CALAFAT J., ROOS D. - Monitoring human basophil activation via CD63 monoclonal antibody 435. J. Allergy Clin. Immunol., 1991, 88, 328-338.
37. SABBAH A. - Étude préliminaire du test d'activation des basophiles à l'aide d'anticorps membranaires par cytométrie de flux dans l'allergie médicamenteuse. Allergie Immunologie, 1995, 27, 274-276.
38. SAINTE-LAUDY J., VALLOON C., GUERIN J.C. - Analyse de l'expression membranaire du marqueur CD63 par activation du basophile humain. Application au diagnostic allergologique. Allergie et Immunologie, 1994, 26, 211-214.
39. GANE P., PECQUET C., CRESPEAU H., LAMBIN P., ABUAF N., LEYNADIER F., ROUGER P. - Flow cytometric monitoring of allergen induced basophil activation. Cytometry, 1995, 19, 361-365.
40. SANZ M.L., SANCHEZ G., GAMBOA P.M., VILA L., UASUF C., CHAZOT M., DIEGUEZ I., DE WECK A.L. - Ag-induced basophil activation: CD 63 cell expression detected by flow cytometry in allergic patients to Dermatophagoides pteronyssinus and Lolium perenne. Clin. Exp. Allergy., 2001, 31, 1007-1013.
41. SAINTE-LAUDY J., SABBAH A., DROUET M., LAURET M.G., LOIRY M. - Diagnosis of venom allergy by flow cytometry. Correlation with cinical history, skin tests, specific IgE, histamine and leukotriene C4 release. Clin. exp. Allergy, 2000, 30, 1166-1171.
42. EBO D.G., LECHKAR B., SCHUERWEGH A.J., BRIDTS C.H., DE CLERK L.S., STEVENS W.J. - Validation of a two-color flow cytometric assay detecting in vitro basophil activation for the diagnosis of IgE-mediated natural rubber latex allergy. Allergy, 2002, 57, 706-712.
43. SANZ M.L., GAMBOA P.M., UASUF C., VILA L., GARCIA-AVILES C., CHAZOT M., DE WECK A.L., - Flow-cytometric basophil activation test by detection of CD63 expression in patients with immedate type reactions to Beta-lactam antibiotics. Clin. Exp. Allergy., 2002, 32, 277-286.
44. ABUAF N., RAJOELY B., GHAZOUANI E., LEVY D.A., PECQUET C., CHABANE H., LEYNADIER F. - Validation of flow cytometry assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J. Allergy clin. Immunol. 1999, 104, 411-418.
45. MONNERET G., BENOIT Y., DEBARD A.L., GUTOWSKI M.C., TOPENOT I., BIENVENU J. - Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs. Clin. Immunol., 2002, 102, 192-199.
46. SABBAH A., SAINTE-LAUDY J., DROUET M., LAURET M.G., LOIRY M. - Réactions anaphylactiques ou anaphylactoïdes au paracétamol. À propos de 3 cas. Allergie et Immunologie, 1997, 29, 60-62.
47. SAINTE-LAUDY J. - Intérêt de l'étude in vivo et in vitro des leucotriènes. Application au cas particulier de l'aspirine. Rev. Fr. Allergol., 1977, 30, 28-35.
48. KOWALSKI M.L., PTASINSKA A., BIENKIEWICZ B., PAWLICZAK R., DU BUSKE L. - Differential effects of aspirin and misoprostol on 15-hydroxyeicosa-tetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients. J. Allergy. Clin. Immunol., 2003, 112, 505-512.
49. KURIMOTO Y., DE WECK A.L., DAHINDEN C.A. - The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation. Eur. J. Immunol., 1991, 21, 361-368.
50. BISCHOFF S.C., BRUNNER T., DE WECK A.L., DAHINDEN C.A. - Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J. Exp. Med., 1990, 172, 1577-1583.
51. MAY A., WEBER A., GALL H., KAUFMANN R., ZOLLNER T.M. - Means of increasing sensitivity of an in vitro diagnsotic test for aspirin intolerance. Clin. Exp. Allergy., 1999, 29, 1402-1411.
52. PLESKOW W.W., STEVENSON D.D., MATHISON D.A., SIMON R.A., SCHATZ M., ZEIGER R.S. - Aspirin-sensitive rhinosinusitis / asthma: spectrum of adverse reactions to aspirin. J. Allergy. Clin. Immunol., 1983, 71, 574-579.
53. SZCZEKLIK A. - Aspirin-induced asthma as a viral disease. Clin. Allergy., 1988, 18, 15-20.
54. NAKAGAWA H., YOSHIDA S., NAKABAYASHI M., AAKAHORI K., SHOJI T., HASEGAWA H., AMAYASU H. - Possible relevance of virus infection for development of analgesic idiosyncrasy. Respiration, 2001, 68, 422-424.
55. ABRAHAMSEN O., HAAS H., SCHREIBER J., SCHLAAK M. - Differential mediator release from basophils of allergic and non-allergic asthmatic patients after stimulation with anti-IgE and C5a. Clin. Exp. Allergy., 2001, 31, 368-378.
56. KIKUCHI Y., KAPLAN A.P. - A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J. Allergy. Clin. Immunol., 2002, 109, 114-
57. JAMES J.M., KAGEY-SOBOTKA A., SAMPSON H.A. - Patients with severe atopic dermatitis have activated circulating basophils. J. Allergy. Clin. Immunol., 1993, 81, 1155-1162.
58. OKASAKA T., ILEA V.S., ROSARIO N.A., RRISMAN R E., ARBESMAN C.E., LEE J.R., MIDDLETON E. - Regulatory role of prostaglandin E in allergic histamine release with observations on the responsiveness of basophil leukocytes and the effect of acetylsalicylic acid. J. Allergy. Clin. Immunol., 1977, 60, 360-366.
59. CELIK G., BAVBECK S., MISIRLIGIL Z., MELLI M. - Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E2 on this release from peripheral blood leukocytes in aspirin-induced asthmatic patients. Clin. Exp. Allergy., 2001, 31, 1615-1622.
60. SCHAFER D., SCHMID M., GODE U.C., BAENKLER B.W. - Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics. Eur. Respir. J., 1999, 13, 638-646.
61. SANAK M., LEVY B.D., CLISH C.B., CHIANG N., GRONERT K., MSTALERZ L., SERHAN C.N., SZCZEKLIK A. - Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur. Respir. J., 2000, 16, 44-49.
62. SOUSA A.R., PARKIH A., SCADDING G., CORRIGAN C.J., LEE T.H. - Leukotriene receptor expression on nasal mucosal inflammatory cells in apsirin-sensitive rhinosinusitis. N. Engl. J. Med., 2002, 347, 1493-1499.
63. HANSCH G.M., ROMER W., VOIGTLANDER V, ROTHER U. - Effect of salicylates onj the complement system : generation of mediators in vivo and in vitro. Clin. Immunol. Immunopathol., 1981, 21, 228-236.
64. VOIGTLANDER V., HANSCH G.M., ROTHER U. - Effect of aspirin on complement in vivo. Int. Archs. Allegy. Appl. Immunol., 1980, 61, 145-149.
65. PLESKOW W.W., CHENOWETH D.E., SIMON R.A., STEVENSON D.D., CURD J.G. -The absence of detectable complement activation in aspirin-sensitive asthmatic patients during aspirin challenge. J. Allergy. Clin. Immunol., 1983, 72, 462-468.
66. CZECH W., SHOPF E., KAPP A. - Release of sulfidoleukotrienes in vitro: ITS relevance in the diagnosis of pseudoallergy to acetylsalicylic acid. Inflamm. Res., 1995, 44, 291-295.
67. BRUNNER B., EBERLEIN-KOENIG B., PRYZBILLA B. - Histamine and sulfidoleukotriene release from peripheral blood leukocytes (PBL) of patients with anaphylactoid reactions provoked by acetylsalicylic acid (ASA) J. Allergy. Clin. Immunol., 1996, 97, 344.
68. WEDI B., KAOO A. - Aspirin induced adverse skin reactions: new pathophysiological aspects. Thorax, 2000, 55 (Suppl 2), S70-S71.
69. MEWES T., RIECHELMANN H., KLIMEK L. - Increased in vitro cysteinyl leukotriene release from blood leukocytes in patients with asthma, nasal polyps and aspirin intolerance. Allergy, 1996, 51, 506-510.
70. WOLANCZYK-MEDRALA A., MATOLEPZY J., MEDRALA W., LIEBHART J., LINVA M., PIETRZAK M. - CAST-ELISA test in diagnosis of aspirin-idiosyncrasy in aspirin-induced asthma. Allergy, 1995, 50 (Suppl. 26), 246.
71. KUBOTA Y., IMAYAMA S., TOSHITANI A., MIYAHARA H., TANAHASHI T., UEMURA Y., KOGA T., SUGAWARA S., KURIMOTO F., HATA K. - Sulfidoleukotriene release test (CAST) in hypersensitivity to nonsteroidal anti-inflammatory drugs. Int. Arch. Allergy Immunol., 1997, 114, 361-366.
72. BUSSE A., CZECH W., SCHOPF E., SIMON J.C. - Der CAST-ELISA in der Diagnostik von pseudoallergischen Reaktionen gegen Nahrungsmitteladditiva und Azetylsalizylsäure. Allergologie, 2000, 23, 110-115.
73. PIERZCHALSKA M., MASTALERZ L., SANAK M., ZALULA M., SZCZEKLIK A. - A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leukocytes precludes its value for aspirin sensitivity testing in asthma. Clin. Exp. Allergy., 2000, 30, 1785-1791.